LBL-024

· Nanjing Leads Biolabs Co.,Ltd

Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for LBL-024, covering 2025-05-22 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: A Phase II Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumour[Substudy 04] [Phase 2]

See pricing